Articles tagged with Antibiotics
New computational simulations suggest that antibiotic treatment can suppress resistant species via attack on sensitive partner species in mutualistic relationships, and spatial arrangement influences cross-protection. The study found that competing species are more susceptible to suppression than mutually interacting species.
Fragment-based lead discovery (FBLD) increases the chances of finding hit compounds and delivers results without high-throughput screening investment. FBLD starts by identifying low molecular weight fragments that bind to protein targets, then grows them into potent drug candidates.
Researchers at the University of British Columbia have created a matchmaking service to pair peptides with antibiotics, increasing treatment success rates against antimicrobial resistant bacteria. Seven combinations were identified that worked better than antibiotics alone, offering up to a 100-fold improvement.
A rapid test can distinguish infants with a specific genetic change from those without it, allowing tailored prescribing and preventing antibiotic-related deafness. The test uses a cheek swab and can produce results in around 40 minutes.
Researchers sequenced the genomes of every microbe in a teaspoon of soil and found hundreds of complex molecules with potential antibiotic or antifungal activity. The discovery is significant as disease-causing bacteria become increasingly resistant to current drugs.
A new study highlights the importance of educating nurses about antimicrobial stewardship and obtaining their buy-in to strengthen antimicrobial stewardship programs (ASPs). The research found that nurse participation leads to closer team coordination, cross-discipline collaboration, and ultimately saves lives.
Researchers have designed a coating infused with antimicrobial agents and mimicking the patterned diamond-like texture of shark skin. The coating effectively killed over 95% of E. coli and 80% of Staphylococcus aureus bacteria when exposed to UV light, making it a potential solution to combat hospital infections.
A study found that travellers carrying standby antibiotics are more likely to use them for mild and moderate diarrhoea, contributing to antimicrobial resistance. The study identified factors increasing antibiotic use among travellers, including carriage of stand-by antibiotics, vomiting, and contact with local healthcare.
A study of almost 15,000 outpatients with acute respiratory infections during flu seasons found that 41% were prescribed antibiotics despite not being indicated for their conditions. Antibiotic overuse remains a widespread issue in the treatment of outpatient acute respiratory infections.
A survey of 211 inpatient providers found that most preferred receiving feedback via email and compared to other providers within their service. The study suggests that anticipating providers' preferences can optimize the impact of antibiotic stewardship programs, improving the use of antibiotics.
Researchers have created new antibiotics that target specific genes in C. difficile bacteria, allowing for precise killing of the infection while sparing other beneficial gut bacteria. The antisense therapy approach has great potential for treating hospital-acquired infections.
Researchers at Penn Medicine found spironolactone as effective as antibiotics in treating women's acne, with similar patient switching rates. The study suggests spironolactone could be a safer and more cost-effective option, reducing antibiotic resistance concerns.
The European Union's action plan aims to address antimicrobial resistance through strong national controls, further research, and global collaboration. The EU plan also prioritizes interoperability in healthcare, including e-prescriptions and personal health records.
A study found that patients' beliefs in the harmlessness of antibiotics can lead clinicians to prescribe them more, despite knowledge of side effects, resulting in increased healthcare costs and adverse reactions. The 'WNTAR' belief can also contribute to antibiotic resistance, a growing global health threat.
A recent GW study reveals that many patients and medical care providers hold a 'Why not take a risk?' mentality when it comes to antibiotics, despite knowing their limitations. This mindset can lead to unnecessary prescribing and the spread of superbugs, causing significant harm.
Cesarean-born babies may be at risk for health problems due to differences in their microbiome. A new review suggests that routine antibiotic administration during C-section deliveries is a major underlying problem, rather than a lack of exposure to vaginal microbes.
An OSU biologist argues that chronic diseases require a restoration ecology approach, similar to natural habitats. By removing unhealthy diets and promoting symbiotic gut microbes, patients can improve their health. The study's findings highlight the importance of personalized medicine and active interventions in treating chronic disease.
A recent study found that most premature infants continue to receive early antibiotics in the first few days of life, highlighting a need for improved neonatal antibiotic stewardship. The majority of very low-birth-weight infants received empirical antibiotic therapy, despite potential risks associated with its use.
A study published in CHEST found that early lactate measurements were associated with improved patient survival, particularly among emergency room patients who received timely tests. The research suggests that abnormal lactate values prompt rapid interventions, leading to better outcomes for sepsis patients.
A significant proportion of patients with suspected sepsis do not have their lactates measured within the recommended timeframe, leading to delayed antibiotic therapy and increased risk of in-hospital death. Earlier lactate measurements correlate with quicker treatment with antibiotics and better outcomes.
Researchers at Martin-Luther-University Halle-Wittenberg found a way to increase the effectiveness of common TB antibiotics while reducing resistance. The new compound blocks the bacteria's pumping mechanism, improving drug efficacy. Tuberculosis is a major global health threat, with 490,000 cases of multi-resistant TB reported in 2016.
The PLOS AMR Channel offers access to the latest research, commentaries, blogs, news, and discussions on antimicrobial resistance (AMR). Key challenges include improving infection prevention, limiting unnecessary antibiotic use, and using existing antibiotics appropriately.
The UK government has invested £1m in the Global Antibiotic Research and Development Partnership (GARDP) to accelerate the development of a new treatment for drug-resistant gonorrhoea. This funding will enable sustainable access to the treatment in low- and middle-income countries, where the burden of infection is greatest.
A study found that patients hospitalized for asthma who received antibiotics had longer hospital stays and higher costs, but no reduced risk of treatment failure. Antibiotic-related diarrhea was also more common in treated patients.
A new study found that a procalcitonin biomarker test had little impact on reducing antibiotic use for patients with suspected lower respiratory tract infections. The trial involved 1,656 adult patients and showed that physicians already commonly withheld antibiotics based on clinical signs alone.
A team of La Trobe University scientists has discovered a peptide found in the flowers of the ornamental tobacco plant Nicotiana alata that can target and destroy Candida albicans cells, making it a promising lead for developing a new class of antibiotics.
A national analysis found treatment costs for drug-resistant MRSA infections are similar to those of susceptible MSSA infections. Researchers attribute the lower costs to factors such as price differences in drugs and possible misdiagnosis or coding errors.
A randomized trial of 383 women with uncomplicated urinary tract infections found that taking ibuprofen instead of antibiotics prolonged symptom duration and increased the risk of serious complications. The study concludes that ibuprofen is not a safe alternative to antibiotics for treating uncomplicated UTIs.
The American Gut Project has collected microbial data from over 11,000 people, revealing associations between diet, antibiotics use, and mental health on the human gut microbiome. The study found that participants who ate more plants had fewer antibiotic resistance genes in their gut microbiomes.
A study has isolated colistin-resistant E. coli from commercial poultry farms in China and hospital patients, revealing the coexistence of mcr-1 and mcr-3 resistance genes on a single plasmid. This finding poses a significant threat to public health due to the spread of antibiotic resistance genes.
The study found a significant increase in hospital-acquired infections caused by antibiotic-resistant Acinetobacter baumannii among US children over a 13-year period. Children with chronic conditions are at higher risk of infection due to compromised immune systems.
A new study reveals that oral antibiotics are associated with an increased risk of developing kidney stones, particularly among children. The risk remains elevated several years after antibiotic use, highlighting the importance of reducing unnecessary antibiotic exposure.
Researchers found a significant association between oral antibiotic use and an increased risk of developing kidney stones in children and adults. The study suggests that disruptions in the intestinal and urinary microbiome may contribute to the occurrence of kidney stones.
Targeted probiotic supplementation in breastfed infants reduces antibiotic resistance genes by 87.5%, including genes associated with respiratory, intestinal, urinary infections, chlamydia, and acne.
A University of Oklahoma led research team is working on a $5.7 million NIH grant to develop more effective approaches against Gram-negative bacteria resistant to conventional treatment. The team aims to overcome the challenge of developing antibiotics that can penetrate through multi-drug efflux pumps and low-permeability membranes.
Scientists at FAU and University of Oxford have discovered a regulatory checkpoint in bacterial gene expression that could be used to develop new antibiotics. This finding has the potential to help overcome antibiotic resistance, which kills around 700,000 people worldwide each year.
Scientists have discovered key steps in how bacteria eat antibiotics, transforming them into food. The findings could lead to new ways to eliminate antibiotics from land and water, slowing the spread of drug resistance. Researchers may engineer bacteria like E. coli to clean up contaminated soil and water.
A study led by UC San Francisco found that treating young children with azithromycin significantly reduced child mortality rates in Sub-Saharan Africa. The intervention resulted in a 13.5% lower overall child mortality rate compared to placebo-treated communities.
A new study published in Molecular Plant-Microbe Interactions reveals the mechanism by which antibiotics kasugamycin and blasticidin S kill fire blight bacteria in apple and pear trees. The researchers found that the antibiotics target a critical gene, ksgA, leading to bacterial death.
Mammary stem cells from dairy cows may help heal damaged tissue and combat bacterial infections, potentially reducing antibiotic use and improving milk quality. The secreted factors of these cells have been shown to promote tissue regeneration, form new blood vessels, and protect epithelial cells from damage.
New research shows that low concentrations of antibiotics can lead to high antibiotic resistance in bacteria, with mutations occurring mainly in genes previously not regarded as typical resistance genes. This highlights the need to prevent further development of resistance.
A new study found that patients with cellulitis treated for six days experienced faster and more frequent relapses at 90 days compared to those treated for 12 days. The study suggested that elderly hospitalized patients with comorbidity may benefit from shorter therapy duration.
A seven-day antibiotic course was shown to be non-inferior to a 14-day course for treating Gram-negative bacteraemia, with similar patient outcomes and faster recovery. The study found reduced antibiotic days and improved return to daily activities in the shorter treatment group.
Researchers found piperacillin-tazobactam significantly less effective than meropenem in treating BSI caused by ceftriaxone-resistant E. coli and K. pneumoniae. The study concluded that piperacillin-tazobactam should be avoided when treating these organisms due to its inferior efficacy.
Researchers have discovered an alternative strategy to combat antimicrobial resistance by repositioning colloidal bismuth subcitrate, which effectively paralyzes multi-resistant superbugs and suppresses the development of antibiotic resistance. The findings offer a promising new approach to treat deadly infections caused by CRE and CRKP.
Researchers found that pepper plants metabolize triclocarban, an antibiotic commonly used in personal care products, into other molecules. The study suggests that these metabolites may have negative health effects, highlighting the need for further research on the impact of environmental triclocarban exposure on human health.
Ear infections, especially in children, can cause severe complications such as meningitis, brain abscesses, and facial paralysis. Modern antibiotic treatments have significantly reduced mortality rates from these conditions, but it is essential to remain vigilant about potential neurologic complications.
Research reveals that advanced treatment technologies on dairy farms do not fully remove antibiotics from manure, leaving behind concerning levels of antibiotic residues. Composting and multistep processes may help reduce these levels, according to lead researcher Diana Aga.
Researchers found that pepper plants metabolize triclocarban, a personal care product antibiotic, leading to potential health concerns. The study's results suggest that the plant's ability to convert the substance into other molecules affects its safety assessment.
Researchers discovered that a common topical antibiotic triggered an antiviral resistance in mice infected with herpes and other viruses. The study found increased expression of genes stimulated by interferons, suggesting a new mechanism for antiviral response.
A new point-of-care test measures CXCL13 concentration in cerebrospinal fluid to diagnose neuroborreliosis, allowing for targeted antibiotic treatment and reducing unnecessary treatments. The test provides quick results, reducing the time between diagnosis and treatment initiation.
A study of over 792,000 children found that acid-suppressing medications and antibiotics used in the first six months of life were associated with an increased risk of developing allergic diseases. The study suggests that these medications may contribute to intestinal dysbiosis, leading to allergies.
A study found that antibiotic use can increase the risk of severe West Nile disease in mice by weakening their immune response. The research suggests that antibiotics can disrupt the balance of gut bacteria, making it harder for the body to fight off viral infections.
A new study found that antibiotics used to treat Chlamydia in koalas can alter the balance of gut microbes necessary for digestion, according to researchers at UC Davis. The study suggests a need to develop antibiotic-free treatments, such as a vaccine, to address this issue.
Antibiotic use surged globally between 2000 and 2015, with defined daily doses increasing by 65% and the consumption rate rising by 39%. The trend was most pronounced in low- and middle-income countries, where antibiotic use rose by 114% and the consumption rate increased by 77%.
Most antibiotic courses for acute sinus infection in adults exceed five days, despite guidelines recommending a maximum of seven days. The study analyzed over 3.7 million visits by private practice physicians and found that nearly 70% of prescribed treatments lasted longer than 10 days.
Infection prevention and control (IPC) and antibiotic stewardship (AS) programs are intrinsically linked to achieve patient safety. Implementing both IPC and AS measures together is more effective than AS measures alone.
A new study reveals that global antibiotic use increased by 39% between 2000 and 2015, with significant increases in low-income and middle-income countries. The study highlights the need for strategies to reduce unnecessary antibiotic use and support alternatives to address the growing threat of drug resistance.
Scientists have successfully created a simplified version of teixobactin, a natural antibiotic discovered in 2015, which has been shown to kill superbug-causing bacteria. The synthetic form was used to treat a bacterial infection in mice, demonstrating its potential as a new class of antibiotic drug.
A study published in Open Forum Infectious Diseases found that patients with drug-resistant infections who received consultation from ID specialists had a 50% lower 30-day mortality rate. ID consultation was also associated with reduced mortality and hospital readmissions for certain types of resistant bacteria.